Table of Contents
Stock Report
Do not mistake temptation for opportunity.
Generated Fri Jan 18 09:19:02 EST 2019.
Ratings are relative rankings calculated by finding the lower bound of Wilson score confidence interval. A rating value close to 1 means a higher probablity of a stock's price high vs price open hitting or exceeding Calculated Target.
Mood
Today's mood: 0.4832005356733173
Watched Stocks
Symbol | Rating | Buy | Sell |
---|
Leads
These 16 stocks represent the top 2% of all considered stocks. 2% = 14
Symbol | Rating | Buy | Sell | Mass | Min | Max | Mean | Median | Stdev | Open Vs High |
---|---|---|---|---|---|---|---|---|---|---|
⬇$JEC1) | 0.858 | 35 | 1 | 26 | 0.000% | 2.393% | 0.852% | 0.617% | 0.790 | |
⬇$BMY2) | 0.794 | 58 | 7 | 205 | 0.108% | 1.733% | 0.927% | 0.942% | 0.546 | |
⬇$BSX3) | 0.759 | 34 | 4 | 142 | 0.169% | 3.059% | 0.688% | 0.371% | 0.860 | |
⬇$HT4) | 0.757 | 12 | 0 | 12 | 0.000% | 3.862% | 1.147% | 0.770% | 1.305 | |
⬇$BHF5) | 0.742 | 22 | 2 | 16 | 0.429% | 2.644% | 1.203% | 1.115% | 0.760 | |
⬇$PBCT6) | 0.706 | 37 | 7 | 68 | 0.307% | 4.392% | 1.774% | 1.505% | 1.528 | |
⬇$DWDP7) | 0.676 | 8 | 0 | 18 | 0.000% | 1.540% | 0.713% | 0.750% | 0.561 | |
⬇$CSX8) | 0.674 | 26 | 5 | 45 | 0.039% | 3.731% | 1.345% | 1.104% | 1.049 | |
⬇$KEY9) | 0.665 | 22 | 4 | 80 | 0.293% | 4.434% | 2.111% | 1.760% | 1.300 | |
⬇$PFE10) | 0.664 | 47 | 13 | 203 | 0.110% | 1.365% | 0.556% | 0.380% | 0.472 | |
⬇$DAL11) | 0.624 | 16 | 3 | 35 | 0.113% | 1.676% | 0.837% | 0.762% | 0.484 | |
⬇$CNP12) | 0.623 | 10 | 1 | 10 | 0.103% | 1.025% | 0.533% | 0.456% | 0.359 | |
⬇$MET13) | 0.623 | 10 | 1 | 28 | 0.000% | 1.298% | 0.454% | 0.454% | 0.399 | |
⬇$GLNG14) | 0.610 | 6 | 0 | 7 | 0.364% | 3.886% | 1.979% | 1.925% | 1.255 | |
⬇$MNST15) | 0.610 | 6 | 0 | 14 | 0.246% | 1.226% | 0.548% | 0.515% | 0.296 | |
⬇$PNR16) | 0.610 | 6 | 0 | 9 | 0.060% | 0.977% | 0.606% | 0.639% | 0.289 |
$JEC
- $JEC: Jacobs to Hold Fiscal First Quarter 2019 Earnings Conference Call …: https://t.co/aH8Knk3ktY
- $JEC: Jacobs’ Board Approves $1 Billion Share Repurchase Authorization …: https://t.co/OTXnlHe6Fy
- $JEC - Jacobs Engineering declares $0.17 dividend https://t.co/4w7zAZMb05
- Analysts See $1.05 EPS for Jacobs Engineering Group Inc. $JEC https://t.co/yOEhapGd3j
- Jacobs Engineering Group Inc. $JEC EPS Estimated At $1.05 https://t.co/Wi9GbhGf8j
- Jacobs Engineering Group Inc. $JEC EPS Estimated At $1.05 https://t.co/MvJcKEolCK
- RT @theflynews: Fly Intel: After Hours Movers $OZK $TEAM $JBHT $GPOR $JEC $PRGS $NFLX $AXP $NLS $CASA https://t.co/Fy0PmLh7GZ
- Fly Intel: After Hours Movers $OZK $TEAM $JBHT $GPOR $JEC $PRGS $NFLX $AXP $NLS $CASA https://t.co/Fy0PmLh7GZ
- Jacobs Engineering Group Inc $JEC Declares Dividend Increase – $0.17 Per Share https://t.co/wynxIojBUk #stocks
- Jacobs Engineering Group Inc $JEC Plans Dividend Increase – $0.17 Per Share https://t.co/lsegCALwor
- RT @Briefingcom: $JEC: Jacobs approves $1 bln share repurchase authorization and increases quarterly dividend by 13% to $0.17/share https:/…
- RT @Briefingcom: $JEC: Jacobs approves $1 bln share repurchase authorization and increases quarterly dividend by 13% to $0.17/share https:/…
- $JEC: Jacobs approves $1 bln share repurchase authorization and increases quarterly dividend by 13% to $0.17/share https://t.co/WAbed5NP4H
- $JEC Jacobs - Jacobs to Hold Fiscal First Quarter 2019 Earnings Conference Call and Webcast From our Stock News Alerts App
- $JEC Jacobs - Jacobs' Board Approves $1 Billion Share Repurchase Authorization and Increases Quarterly Divide From our Stock News Alerts App
- $JEC OKs $1B Share Buyback Program https://t.co/riGbvTHZGp
- short % to float of $KBR is 2.77 at 2018-12-31 https://t.co/6of6fN0UaL $MDR 18.36% $GVA 7.76% $JEC 2.77%
- $JEC - Jacobs approves $1B share repurchase authorization https://t.co/DX5VySrgKz
- New York State Common Retirement Fund Has Cut Jacobs Engineering Group $JEC Holding by $3.59 Million as Valuation D… https://t.co/qn5jwyEzqx
- Submission of Matters to a Vote of Security https://t.co/GPHu6L0fil $JEC
- $JEC Jacobs - 8-K (Current report filing) SEC Filing From our Stock News Alerts App
- Jacobs approves $1B share repurchase authorization $JEC https://t.co/IQAgy72IaP https://t.co/ysTxMxhVOi
- https://t.co/e9pMF9IP9s Best Swing Trader with Stock Alerts! $FMC $NVDA $JEC
- Jacobs Engr Group $JEC Shareholder Coastline Trust Co Has Trimmed Its Holding by $466,640 as Stock Value Declined;… https://t.co/dux1CfrcDs
- BidaskClub top 50 #StronglyBought $HCA $ZBRA $HRC $BCE $TMO $COP $NGG $TM $HMC $ABEV $BIIB $PBRA $PBR $VALE $RIO… https://t.co/gGMhLCj5OP
- Gapping up: $OZK +14.3%, $TEAM +8.6%, $CFG +6.9%, $VFC +6.5%, $JBHT +6%, $STI +5.1%, $GPOR +5%, $PCG +4.7%, $ACB +3… https://t.co/PGyahE4TsQ
$BMY
- Top #moneyflow for #sp500 today $BMY $PCG $PFE $BAC $DNB $MS $NKE $CSCO $JNJ $JPM ... https://t.co/S59zN0R1wP
- RT @OpenOutcrier: RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $Z…
- RT @OpenOutcrier: RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $Z…
- RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $ZNGA
- RT @OpenOutcrier: RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $Z…
- Lilly's 10-day sprint for Loxo could put other names on the table $LLY $LOXO $BMY $CELG $GSK $TSRO $CLVS $AZN $BPMC… https://t.co/8HjG1sypCK
- #rally #trade talks $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS… https://t.co/YL4wzQXAc9
- Call buyers in $BMY. Hasn’t budged since the $CELG selloff https://t.co/skmVlmRGun
- RT @TomWhite_TDAN: Want Unusual Option Activity?! #UOA Check out this report on $BMY Call Buyers ahead of key earnings next week post $CELG…
- RT @TomWhite_TDAN: Want Unusual Option Activity?! #UOA Check out this report on $BMY Call Buyers ahead of key earnings next week post $CELG…
- #estate asset watch - top money flow today ( price x volume ) $AMZN $NFLX $AAPL $BAC $MSFT $BABA $FB $MS $NVDA $AMD… https://t.co/KI7OOBK1BB
- Want Unusual Option Activity?! #UOA Check out this report on $BMY Call Buyers ahead of key earnings next week post… https://t.co/rzVJvfzhl4
- Top #moneyflow for whole #market today $SPY $SHV $AGG $USFR $BSV $BMY $CDC $CDL $VYM $IWD ... https://t.co/S59zN0R1wP
- As a stand alone, I have $CELG earning $11 a share in 2019 @ $14 a share in 2020 $16-17 in 2021 and $19-20 a share… https://t.co/BFjBAVWMEd
- Top #money flow today. Free stocks app https://t.co/B6pljuv3p6 $SPY, $EEM, $SHV, $AMZN, $AGG, $VTI, $USFR, $EMB,… https://t.co/3gZa4xWp8W
- $GILD $BMY: 1 Chart That Shows Why Celgene Has Been Bought Out and Gilead …: https://t.co/QA6fo2MYyz
- $BMY: New SEC Filing for BMY: Form 425 (No. 0001140361-19-001258): https://t.co/YSNDqBZHYU
- $CELG $BMY Bristol-Myers Squibb Company SEC Filing: Form 425 https://t.co/O3qpac2FxP
- $TFX $FDC $MS $BA $HAL $CVS $UNP $ABBV $GDOT $SYY $EMR $BMY $BRKB $C $KO $M $UNH $RTN $ED $MCD $CVX $JPM Largest MO… https://t.co/jCnPTdiK3I
- $ABBV short ratio on 2018-12-31 is 4.32 https://t.co/Ou6PdPtZzR $GSK 1.56 $BMY 1.35 $LLY 1.70 $AZN 2.72
- $BAC $AAPL $GE $MU $NFLX $AMD $NVDA $FB $BABA $PCG $CAT $MSFT $MS $SQ $BMY $AMZN $GS $VAC $WFC $F $QCOM $T $JPM… https://t.co/T7S2Aik9NZ
- RT @BentheFidler: ICYMI earlier: Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter https://t.co/VrrCzi8Wy2 $MRK $BMY $G…
- $BAC $GE $AAPL $MSFT $WFC $AMD $MU $CAT $BMY $SIG $FCX Highest volume strikes https://t.co/GKvz4y9LFk
- 2019-01-16 Short sale volume (not short interest) for $CLDX is 45%. https://t.co/l6L5TjJrmf $PFE 33% $GSK 58% $BMY 47% $SGEN 54%
- Short sale vol (not short interest) for $CLDX on 2019-01-16 is 45%. https://t.co/l6L5TjrPXF $BMY 47% $AMGN 48% $SGEN 54% $GSK 58%
- According to Sources M&A podcast touches on $CELG $BMY arbitrage spread this week https://t.co/htWVfD60FH
- If $bmy goes up on a given day, $celg should be up a similar amount. Makes zero sense why $bmy is up today and $celg down.
- RT @WallStJesus: $BMY REPEAT BULL SWEEPERS
- $SPY $QQQ $IWM $BABA $AAPL $FB $NVDA $NFLX $ROKU $CELG $BMY $IBB $BMY For Trade Ideas/Alerts/Live trading 9-4pm J… https://t.co/GfNs7JsnTe
- $GILD $CELG $ROKU $CPRI $FB $AAPL $BMY $LVS $M $SPY $QQQ $IWM $TGT $ROST $CGC $STZ $SWKS $TWTR $LLY $HD $LOW For T… https://t.co/vFnDmV7eDp
- Unusual calls: $ACB $ZNGA $MRK $BMY $MSFT $CS $CVE $EBAY $NIO $PCG $ARNC $VIPS $SQ $GLNG
- RT @TickwatcherMF: Top #money flow today. Free stocks app https://t.co/B6pljuMEgE $SPY, $EEM, $SHV, $AMZN, $AGG, $VTI, $USFR, $EMB, $BSV, $…
- Top #money flow today. Free stocks app https://t.co/B6pljuMEgE $SPY, $EEM, $SHV, $AMZN, $AGG, $VTI, $USFR, $EMB,… https://t.co/8x9izghra5
- $BMY every single arb asks why Bristol is trading back up. No matter what the chance or reality that anyone would r… https://t.co/zZsFG0ly1b
- I added a video to a @YouTube playlist https://t.co/UmSimhkn1U Carlos and Robert #DayTrading Recap $BMY Jan 03 2019 #TradingRecap
- RT @TopStockAlerts1: Unusual calls: $ACB $ZNGA $MRK $BMY $MSFT $CS $CVE $EBAY $NIO $PCG $ARNC $VIPS $SQ $GLNG
- RT @TraderHangout: $GILD $CELG $ROKU $CPRI $FB $AAPL $BMY $LVS $M $SPY $QQQ $IWM $TGT $ROST $CGC $STZ $SWKS $TWTR $LLY $HD $LOW For Trade…
- RT @TraderHangout: $SPY $QQQ $IWM $BABA $AAPL $FB $NVDA $NFLX $ROKU $CELG $BMY $IBB $BMY For Trade Ideas/Alerts/Live trading 9-4pm Join t…
- RT @ArbCapitol: $BMY every single arb asks why Bristol is trading back up. No matter what the chance or reality that anyone would reach for…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and… https://t.co/m2hFXKK6eD
- $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future.… https://t.co/CbYLSPQw1x
- $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued oper… https://t.co/fFjE2yOT4c
- $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent fil… https://t.co/Z5IZhcc7OF
- $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal… https://t.co/G23vFDY2Yj
- $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-… https://t.co/vEevaMBmxd
- $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already… https://t.co/hBPWg90vih
- $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been ide… https://t.co/1IiCdBZK3z
- $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA… https://t.co/g9DOPOwSyq
- RT @TravisHoward5: #unusualoptionactivity $SPY $BAC $QQQ $GE $EEM $AAPL $AMD $FXI $IWM $XLF $SQ $FB $BABA $NVDA $JD $PBR $X $QCOM $TRIP $TS…
- #unusualoptionactivity $SPY $BAC $QQQ $GE $EEM $AAPL $AMD $FXI $IWM $XLF $SQ $FB $BABA $NVDA $JD $PBR $X $QCOM… https://t.co/550KMXPmsd
- $BMY high OI range is 50.00 to 51.00 for option expiration 02/01/2019 #maxpain #options https://t.co/ndI7yHixsg https://t.co/ixYJ4OoMb9
- RT @eWhispers: #earnings season $AAPL $NFLX $FB $BAC $C $JPM $GE $UNH $BA $DAL $CLF $T $GS $WFC $PYPL $GOOGL $INTC $F $TWTR $MA $V $JNJ $…
- RT @raymond10mm: #rally #trade talks $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS $UNH $V…
- https://t.co/GfU0paTh5N Verified $26.89 loss in $BMY 2019
- Celgene and Bristol-Myers Squibb – Undervalued and Underappreciated @antya_neeraj $BMY #UnitedStates #HealthCare… https://t.co/DMP9vbx37c
- Short sale vol (not short interest) for $ABT on 2019-01-17 is 57%. https://t.co/lpCa2LthUS $BSX 42% $BMY 48% $JNJ 46% $PFE 36%
- For those of you who used to participate in the $CELG Roulette setting a year end price target please be informed t… https://t.co/gXzLBbBhcU
- $CELG intent to maintain same equity % shareholding in $XLRN following recent share issue https://t.co/GtjfryPb6w… https://t.co/0XBMCz9lQ1
- top money flow Thursday ( price x volume ) $AMZN $NFLX $AAPL $BAC $MSFT $BABA $FB $MS $NVDA $AMD $GS $SQ $FISV $JPM… https://t.co/gC1s2TC2sY
- most active stocks Thursday - $BAC $GE $PCG $AMD $FDC $F $MS $ACB $ECA $MU $AAPL $VALE $SNAP $KEY $MSFT $WFC $KMI… https://t.co/pSSfLqeCRm
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- Short sale volume (not short interest) for $ACHN at 2019-01-17 is 46%. https://t.co/tJqXcTahNQ $MRK 55% $BMY 48% $JNJ 46% $GSK 66%
- Short sale volume(not short interest) for $ACHN on 2019-01-17 is 46%. https://t.co/tJqXcTahNQ $JNJ 46% $MRK 55% $BMY 48% $GSK 66%
- Bristol Myers Squibb Co $BMY Holder Mark Sheptoff Financial Planning Has Trimmed Its Position by $492,636 as Stock… https://t.co/O9VFXRvTOa
- Drugmakers Raise Prices Amid Shortages, Recalls - WSJ where is #MartinShkreli to blame? #BigPharma $pfe $bmy $spy https://t.co/gqeKUeN0Rz
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- most active options Thursday - $BAC $AAPL $GE $NVDA $GS $FB $PG $BABA $F $C $PCG $SNAP $MS $AMD $NFLX $M $VAC $MSFT… https://t.co/qU6jMRdbA8
- #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of min… https://t.co/5Oolrki11g
- #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committ… https://t.co/EcHJN4ZnY9
- #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-00… https://t.co/Xu0YJzHMiz
- #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for… https://t.co/Dd7XKlEfEZ
- #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QB… https://t.co/wZGx1gzeU2
- #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth i… https://t.co/sW6dPvdEPO
- #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimall… https://t.co/q1eKMTDggH
- RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has alre… https://t.co/BWIWBQPm8E
- RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally ver… https://t.co/FQcXFJUdB2
- RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent… https://t.co/eTUAtl2ElK
- RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut… https://t.co/vBEuDmAFCA
- #Biotech Roundup: Aimmune Drama, #Shutdown Blues, Perlmutter Talks Cancer https://t.co/Un4P6efKLf $MRK $AIMT $AMGN $BMY $LLY $FPRX
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- Some of todays top open interest changes 1.18.19 $BAC $MU $GE $BMY $ARNC https://t.co/Txs0r6myFK
- RT @UPBOptionMil: Some of todays top open interest changes 1.18.19 $BAC $MU $GE $BMY $ARNC https://t.co/Txs0r6myFK
- RT @UPBOptionMil: Some of todays top open interest changes 1.18.19 $BAC $MU $GE $BMY $ARNC https://t.co/Txs0r6myFK
- RT @BentheFidler: #Biotech Roundup: Aimmune Drama, #Shutdown Blues, Perlmutter Talks Cancer https://t.co/Un4P6efKLf $MRK $AIMT $AMGN $BMY $…
- Top buy stocks: $AA, $AKS, $BMY, $JBLU, $LLY, $MDT, $NWL, $UAL https://t.co/rOuzwjmXKo
- $BAC $MU $GE $BMY $WFC $AAPL $F $KHC $VIPS $C $NIO $ARNC $RF $ACB $CLF $MRK $SIG $PCG $JPM Largest CALL OI increases https://t.co/2wzqpkBbPu
- @Biotech2050 @ByMadeleineA Luspartecept will be a huge blockbuster kill the deal with $BMY and buy $XLRN
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- $CELG $BMY: Ahead of Bristol Myers purchase, Celgene partners with Boston …: https://t.co/GcxsNp6mcg
- $CELG $BMY Celgene teams up with Obsidian Therapeutics in cell therapies https://t.co/JsEdKI6kdo
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
$BSX
- percent change7d (descending order) $OBTC 2168.0% $SIM 946.12% $XSD 832.36% $X12 724.85% $ETA 513.63% $NOKU 468.04%… https://t.co/bPZ2rji45S
- percent change24h (descending order) $X12 1294.51% $GRIM 906.31% $2GO 578.22% $BSX 461.13% $OBTC 450.84% $XSD 307.7… https://t.co/5sVr1XIgGy
- percent change24h (descending order) $X12 1294.51% $GRIM 806.74% $BSX 461.06% $2GO 456.54% $OBTC 450.84% $XSD 308.4… https://t.co/aI9saPiHhD
- percent change7d (descending order) $OBTC 2168.0% $XSD 1115.37% $SIM 950.78% $X12 724.85% $ETA 535.37% $BSX 466.5%… https://t.co/AXcHlnKJL2
- Brokerages Expect Boston Scientific Co. $BSX Will Announce Earnings of $0.37 Per Share https://t.co/esbtIAGXCy
- Zacks: Analysts Anticipate Boston Scientific Co. $BSX Will Post Quarterly Sales of $2.56 Billion https://t.co/4gzOFUld9Z
- Analysts Expect Boston Scientific Co. $BSX Will Post Quarterly Sales of $2.56 Billion https://t.co/tICtSql5V4
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and… https://t.co/m2hFXKK6eD
- $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future.… https://t.co/CbYLSPQw1x
- $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent fil… https://t.co/Z5IZhcc7OF
- $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal… https://t.co/G23vFDY2Yj
- $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-… https://t.co/vEevaMBmxd
- $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already… https://t.co/hBPWg90vih
- $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been ide… https://t.co/1IiCdBZK3z
- $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA… https://t.co/g9DOPOwSyq
- $NSPX Sabby capital 1.8bil hedgefund specialize in BIG #BIOTECH why LOAD a pennystock?! https://t.co/p2lvo3BQAx… https://t.co/esvJBbeEZ6
- percent change7d (descending order) $XSD 1499.83% $IND 1338.13% $OBTC 864.33% $SIM 822.67% $X12 724.85% $PPP 721.18… https://t.co/jgB0otEsZl
- percent change24h (descending order) $IND 1477.25% $X12 1294.51% $PPP 875.15% $PASS 606.57% $GRIM 603.6% $BSX 458.8… https://t.co/QxJnQfVr7R
- Short sale vol (not short interest) for $ABT on 2019-01-17 is 57%. https://t.co/lpCa2LthUS $BSX 42% $BMY 48% $JNJ 46% $PFE 36%
- 2019-01-17 Short sale volume (not short interest) for $BSX is 42%. https://t.co/N0V5R8K0oM $ANGO 40% $SYK 48% $TFX 59%
- percent change7d (descending order) $XSD 1838.63% $IND 1421.02% $OBTC 934.66% $SIM 824.25% $X12 724.85% $PPP 721.18… https://t.co/eVxjpBIcU7
- percent change24h (descending order) $IND 1598.2% $X12 1294.51% $PPP 875.15% $GRIM 642.38% $BSX 459.17% $2GO 420.74… https://t.co/UkNgnvdVBh
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- percent change7d (descending order) $XSD 2792.87% $SIM 932.3% $OBTC 795.89% $IND 783.32% $X12 724.85% $PPP 721.18%… https://t.co/ATGbJaOE52
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of min… https://t.co/5Oolrki11g
- #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committ… https://t.co/EcHJN4ZnY9
- #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-00… https://t.co/Xu0YJzHMiz
- #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for… https://t.co/Dd7XKlEfEZ
- #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QB… https://t.co/wZGx1gzeU2
- #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth i… https://t.co/sW6dPvdEPO
- #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimall… https://t.co/q1eKMTDggH
- RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has alre… https://t.co/BWIWBQPm8E
- RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally ver… https://t.co/FQcXFJUdB2
- RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut… https://t.co/vBEuDmAFCA
- percent change7d (descending order) $XSD 3925.51% $OBTC 1576.22% $SIM 834.84% $X12 724.85% $PPP 721.18% $IND 607.54… https://t.co/9V9b31GcC9
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- Maulik Nanavaty Sells 3,038 Shares of Boston Scientific Co. $BSX Stock https://t.co/Wn1zSknpgO
$HT
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/fdWgPl5W4U $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/e9J1XapHko
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/MlD4RDhhuk $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/lboDZFWp6b
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/MlD4RDhhuk $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/2Ah40eB0KZ
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/fdWgPl5W4U $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/qCZe7TkgA6
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/MlD4RDhhuk $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/xPOyfv3mz4
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/fdWgPl5W4U $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/zMeQytigw4
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/MlD4RDhhuk $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/6FfbC4yAgz
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/fdWgPl5W4U $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/inX9mPvNTj
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/fdWgPl5W4U $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/lIYV4RofP4
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/MlD4RDhhuk $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/ZNTqcGWYgN
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/fdWgPl5W4U $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/vpGaSxZcNF
- Buy Bitcoin at bitMEX Leverage are enormous ➡️ https://t.co/MlD4RDhhuk $EMC $SMART $POE $RLC $HT $ENJ $BNB $DTR… https://t.co/kGcfODmHvt
$BHF
- Analysts See $2.09 EPS for Brighthouse Financial, Inc. $BHF https://t.co/ehZPzCyEpL
- Analysts See $2.09 EPS for Brighthouse Financial, Inc. $BHF https://t.co/hqehhkAyAB
- Brighthouse Financial, Inc. $BHF EPS Estimated At $2.09 https://t.co/2xVEeQXX10
- As of February, 11 The EPS for Brighthouse Financial, Inc. $BHF Expected At $2.09 https://t.co/4L5K7l9XnR
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- Brighthouse Financial $BHF Rating Increased to Sell at BidaskClub https://t.co/VVMS6quETN
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- RT @StockTweetsHQ: Call A Spade A Spade_Guard Dog $GRDO Share Price To Rise As CEO George Sharp Exposes iHub Message Board As A Criminal En…
- $BHF: Brighthouse Financial Announces Conference Call to Discuss …: https://t.co/E1OafRLPli
- $BHF Brighthouse Financial Announces Conference Call to Discuss Fourth Quarter 2018 Results https://t.co/MoDKfdurPx
$PBCT
- Fri (1/17/19) strongest final 30-min close (Min $5, Vol > 1.5M, Opt Vol in any strike > 750): $PCG $ADNT $CSX $PBCT… https://t.co/geiRkeiyUW
- Thurs (1/17/19) trading range % > 90% (Min $5, Vol > 1.5M, Opt Vol in any strike > 750): $MCD $MYL $MAC $BAC $VFC… https://t.co/ocfF6qUJ7u
- $PBCT Listen to Q4 2018 People's United Financial, Inc. Earnings Call live at 05:00 PM, ondemand after - https://t.co/DCjqdwEULD
- $PBCT: People’s United Financial Declares Cash Dividend on Preferred Stock: https://t.co/Ke48LSNlo2
- $PBCT earnings are out!! - Get Chart, Ratings, Trade Ideas https://t.co/C95erefGrn
- $PBCT: People’s United Bank Acquires VAR Technology Finance, an …: https://t.co/jN7wbCcy3Q
- $PBCT - People's United Financial beats by $0.02, misses on revenue https://t.co/veNhHvguN9
- RT @eWhispers: #earnings scheduled after the close today and before the open tomorrow $NFLX $AXP $SLB $TEAM $JBHT $VFC $STI $RF $KSU $PRG…
- $PBCT I hope doesnt let me down...so far so good.
- $PBCT - People's United Financial declares $0.1750 dividend https://t.co/x0H6toJj6M
- AH Price &/or Vol Leaders (a/o5:51pmEST): $OZK $TEAM $BIOC $PBCT $GPOR $FLKS $JBHT $ACB $PLUG $DRIP $BPTH $AGEN https://t.co/KHv32thtQJ
- $PBCT - People's United Financial jumps 6.0% after Q4 beats, VAR buy https://t.co/nDgaFW7Vu0
- $PBCT - People's United Bank buys equipment finance company https://t.co/BIQnlCP8HU
- People’s United Financial, Inc. $PBCT Announces Quarterly Dividend of $0.18 https://t.co/Z3TsXszXXH
- People’s United Financial, Inc. $PBCT to Issue $0.18 Quarterly Dividend https://t.co/gUC6MpZgyM
- People’s United Financial, Inc. $PBCT Announces Quarterly Dividend of $0.18 https://t.co/aMFgeW5Gdn #stocks
- RT @eWhispers: #earnings scheduled after the close today and before the open tomorrow $NFLX $AXP $SLB $TEAM $JBHT $VFC $STI $RF $KSU $PRG…
- RT @eWhispers: #earnings scheduled after the close today and before the open tomorrow $NFLX $AXP $SLB $TEAM $JBHT $VFC $STI $RF $KSU $PRG…
- $PBCT: People's United Financial subsidiary People's United Bank announces acquisition of VAR Technology Finance https://t.co/La7kbOFUKh
- $PBCT: People’s United Financial jumps 6.0% after Q4 beats, VAR buy: https://t.co/RFeMa6lixt
- RT @Briefingcom: $PBCT: People's United Financial beats by $0.02, reports revs in-line https://t.co/bp37DNqX9e
- $PBCT: People's United Financial beats by $0.02, reports revs in-line https://t.co/bp37DNqX9e
- NASDAQ:PBCT $PBCT - People's United Financial declares $0.1750 dividend https://t.co/7pLQIk6Ldl
- RT @eWhispers: #earnings scheduled after the close today and before the open tomorrow $NFLX $AXP $SLB $TEAM $JBHT $VFC $STI $RF $KSU $PRG…
- Popular: $IMMU, $GPOR, $MNST, $NLS, $PBCT
- Explore #fundamental numbers and pros and cons for $PBCT https://t.co/vjG0uEsEAG
- $PBCT announced a 0.175 dividend. Annual Yld is 4.3%. PBCT raised its dividend 3 times in 3 yrs. https://t.co/p6t1LvmESz
- $PBCT Max Pain is 17.00 for maturity 02/15/2019. #maxpain #options https://t.co/CyQ5SQ9hN7 https://t.co/ufKZS7y4yn
- The *largest gainers in after hours* for you to watch tomorrow: $NTN $CADC $SNNA $ACMR and $PBCT. https://t.co/WhpCO8rUeQ
- After Hours Movers to watch: $TEAM $BIOC $PBCT $GPOR $FLKS $ACB $PLUG $DRIP $BPTH $AGEN
- Thursday's After-Hours Movers $NLS, $JBHT, $PBCT, $GPOR, $NFLX https://t.co/MqZa8e6VHX
- AH Closing Price &/or Vol Leaders (a/o8pmEST): $UPL $OZK $TEAM $BIOC $JBHT $GPOR $VKTX $PBCT $ACB $ZAYO $CGC $CTL https://t.co/5VQNC2AHRO
- People’s United Financial $PBCT Announces Earnings Results https://t.co/vQD3bDXAGF
- RT @eWhispers: #earnings scheduled after the close today and before the open tomorrow $NFLX $AXP $SLB $TEAM $JBHT $VFC $STI $RF $KSU $PRG…
- $PBCT: People’s United Financial Inc (PBCT) Q4 2018 Earnings Conference …: https://t.co/JFGbLrrdVi
- People’s United Financial $PBCT Issues Earnings Results, Beats Estimates By $0.02 EPS https://t.co/gcmftKx3ZQ #stocks
- People’s United Financial $PBCT Releases Earnings Results https://t.co/caT1wLK1Cz
- RT @eWhispers: #earnings scheduled after the close today and before the open tomorrow $NFLX $AXP $SLB $TEAM $JBHT $VFC $STI $RF $KSU $PRG…
- Zacks: Analysts Anticipate People’s United Financial, Inc. $PBCT to Post $0.34 Earnings Per Share https://t.co/RrxJQqZltE
- Zacks: Brokerages Expect People’s United Financial, Inc. $PBCT to Post $0.34 EPS https://t.co/DUs04qZbUS #stocks
- Zacks: Brokerages Expect People’s United Financial, Inc. $PBCT to Post $0.34 EPS https://t.co/LCNuHgnC2H
- Recommendation #HOLD for $PBCT with UB rating - 2.76 out of 5. https://t.co/oKjH4WrlRT
- $NFLX $AXP $SLB $LVS $MGM $NLY $AUY $ABX $CELG $ZNGA $CX $UAA $NKE $FL $TEAM $JBHT $VFC $STI $RF $KSU $PRGS $CFG… https://t.co/qCtfUXnhKF
- Wondering about risks of $PBCT? The 21-day volatility is 7.79% https://t.co/eNNaODqcgk
- $PBCT: People’s United Financial, Inc. (PBCT) CEO John Barnes on Q4 …: https://t.co/VuzZ01b5F1
- $PBCT - People's United Financial, Inc. (PBCT) CEO John Barnes on Q4 2018 Results - Earnings Call Transcript https://t.co/Zs7Zfk7B5s
- names with 5 straight days of gains - $TKC $LULU $NTNX $ZBRA $MTB $CMA $BK $EEFT $VOYA $PM $BKI $USB $VICI $PBCT… https://t.co/xhlbwahGIW
- Tech Data $TECD Share Value Rose While Advisory Research Has Lowered by $4.53 Million Its Stake; Brookstone Capital… https://t.co/AkSMjNTG2q
- RT @behindthebid: 16 co's reporting earnings today / last night, sorted by market cap: $PRGS,1,624 M $OZK,3,550 M $FHN,4,752 M $PBCT,6,040…
- 16 co's reporting earnings today / last night, sorted by market cap: $PRGS,1,624 M $OZK,3,550 M $FHN,4,752 M $PBCT,… https://t.co/68XYvDrXse
- $PBCT - People's United Bank acquires VAR Technology Finance https://t.co/QOquBaqJiE
- RT @behindthebid: 16 co's reporting earnings today / last night, sorted by market cap: $PRGS,1,624 M $OZK,3,550 M $FHN,4,752 M $PBCT,6,040…
- RT @behindthebid: 16 co's reporting earnings today / last night, sorted by market cap: $PRGS,1,624 M $OZK,3,550 M $FHN,4,752 M $PBCT,6,040…
- S&P 500 - Gap Up https://t.co/Wsz260sXUL $VFC $STI $SLB $PBCT $FCX $ANET $SYMC $TXN $AVGO $STZ $CFG $CVS $FTI $AA $FLR $JBHT $HPQ $HAL
- $SPX #stock $PBCT beats #earnings estimates, up premarket #trading
- RT @TopMarketGainer: $QBIO is our new low-float biotech alert. CEO hints at upcoming FDA approval in recent radio interview! Click here for…
- RT @OpenOutcrier: $PBCT (+0.6% pre) People's United Financial Q4 beats, VAR buy - SA https://t.co/gEva6zN7TB
- RT @OpenOutcrier: $PBCT (+0.6% pre) People's United Financial Q4 beats, VAR buy - SA https://t.co/gEva6zN7TB
- $PBCT (+0.6% pre) People's United Financial Q4 beats, VAR buy - SA https://t.co/gEva6zN7TB
- RT @TopMarketGainer: $QBIO is our new low-float biotech alert. CEO hints at upcoming FDA approval in recent radio interview! Click here for…
- People’s United Financial, Inc. $PBCT Plans $0.18 Quarterly Dividend https://t.co/Xl5jpW3KjB
- $QBIO is our new low-float biotech alert. CEO hints at upcoming FDA approval in recent radio interview! Click here… https://t.co/r9i3do6VXr
- Gapping up: $OZK +14.3%, $TEAM +8.6%, $CFG +6.9%, $VFC +6.5%, $JBHT +6%, $STI +5.1%, $GPOR +5%, $PCG +4.7%, $ACB +3… https://t.co/PGyahE4TsQ
$DWDP
- $DWDP: Corteva Agriscience™, Agriculture Division of DowDuPont …: https://t.co/JqZUkfHYQk
- Will US ease trade tariffs on China during talks? $spy $dia $iwm $uso $gld $fxi $baba $sina $bidu $xle $xlf $xlk… https://t.co/L6cir7huCr
- $DWDP DWDP leads the way today as the best performing mega cap stock, closing up 2.96%. https://t.co/Odbeg9Q0SZ
- Thurs (1/17/19) trading range % > 90% (Min $5, Vol > 1.5M, Opt Vol in any strike > 750): $MCD $MYL $MAC $BAC $VFC… https://t.co/ocfF6qUJ7u
- $dwdp Dow Dupont showing a nice false breakdown on the weekly with bullish momentum divergence https://t.co/xhNLLAFqfd
- RT @tpetruno: Industrial stocks led the rally today, another vote for a continuing global economic expansion. Northrop $NOC +3.3% DowDuPo…
- $DWDP Dowdupont Inc. Option Order Flow Sentiment has Turned from Bearish to Bullish. https://t.co/hM8PjmDMnE
- Industrial stocks led the rally today, another vote for a continuing global economic expansion. Northrop $NOC +3.… https://t.co/K01s9G53iS
- $DWDP: DowDuPont ag unit plans commercial launch of Enlist E3 soybeans: https://t.co/S9NjZ9yMNg
- $DWDP - DowDuPont ag unit plans commercial launch of Enlist E3 soybeans https://t.co/JP2JkUXhxu
- RT @SeanaNSmith: Dow leaders: $GS $AAPL $DWDP $AXP https://t.co/3760Hh6OqQ
- really interesting Deloitte study on measuring pharma return on R&D (and analyzing declining productivity); have be… https://t.co/NDnnFCvvM5
- $RGSE $DWDP $TSLAQ - Psssst. Real Good Solar's Powerhouse™ Solar Shingles are made by this little firm Dow Chemical… https://t.co/bIDvX4QeSY
- Thur (1/17) highest trading range > 80% compared to open (Min $5, Vol > 750K, Opt Vol in any strike > 100): 98 -… https://t.co/z3xbQ4Ck94
- DowDuPont Inc $DWDP Receives Average Recommendation of “Buy” from Brokerages https://t.co/VaEJpfK8Vx #stocks
- DowDuPont Inc $DWDP Receives Average Recommendation of “Buy” from Brokerages https://t.co/76Fq60tqsV
$CSX
- RT @fklivestolearn: StocksToWatch: $MS, $EA, $CRM, $PCG, $S, $BDX, $AA, $CSX, $CARS, $GCI, $AAPL, $GS, $LPCN, $ZFGN, $ADMP, $UNG, $MRTX, $S…
- The #ChipStocks May Lead The Stock Market Lower $NXPI $TSM $SMH $AAPL $SPY $CSX $MS https://t.co/s45Yocv6y1
- RT @BatScientist: A Peek Into The Markets: US Stock Futures Down, Morgan Stanley Earnings Miss In Focus $BBT $CBSH $CSX via @benzinga https…
- RT @BrandonVanZee: 9 at 9™ – 01/17/19 https://t.co/EW27WLfoYg via @market_scholars #9at9 #premarket #stocks + $PCG $MTB $BDX $CBS $SQ $APY…
- TODAYS LIVE TRADING WEBINAR RE-CAP FOR 1/17/2019 $LPCN SHORT $3.5 to $2 $NFLX LONG $347 to $355 $SIG SHORT $28 to $… https://t.co/6JBn2kbnhO
- RT @BrandonVanZee: 9 at 9™ – 01/17/19 https://t.co/EW27WLfoYg via @market_scholars #9at9 #premarket #stocks + $PCG $MTB $BDX $CBS $SQ $APY…
- #estate asset watch - top money flow today ( price x volume ) $AMZN $NFLX $AAPL $BAC $MSFT $BABA $FB $MS $NVDA $AMD… https://t.co/KI7OOBK1BB
- Grisanti Capital Management Has Decreased Facebook $FB Position by $1.62 Million; As C S X $CSX Shares Declined, Fo… https://t.co/nWkkp8UqJ5
- Fri (1/17/19) strongest final 30-min close (Min $5, Vol > 1.5M, Opt Vol in any strike > 750): $PCG $ADNT $CSX $PBCT… https://t.co/geiRkeiyUW
- RT @BrandonVanZee: 9 at 9™ – 01/17/19 https://t.co/EW27WLfoYg via @market_scholars #9at9 #premarket #stocks + $PCG $MTB $BDX $CBS $SQ $APY…
- RT @BrandonVanZee: 9 at 9™ – 01/17/19 https://t.co/EW27WLfoYg via @market_scholars #9at9 #premarket #stocks + $PCG $MTB $BDX $CBS $SQ $APY…
- RT @BrandonVanZee: 9 at 9™ – 01/17/19 https://t.co/EW27WLfoYg via @market_scholars #9at9 #premarket #stocks + $PCG $MTB $BDX $CBS $SQ $APY…
- Thurs (1/17/19) trading range % > 90% (Min $5, Vol > 1.5M, Opt Vol in any strike > 750): $MCD $MYL $MAC $BAC $VFC… https://t.co/ocfF6qUJ7u
- RT @AjTrader7: TODAYS LIVE TRADING WEBINAR RE-CAP FOR 1/17/2019 $LPCN SHORT $3.5 to $2 $NFLX LONG $347 to $355 $SIG SHORT $28 to $25 $LMFA…
- Thurs (1/17/19) earnings +/- % from OR 30-min high, Up/Avg Gain of today’s thirteen 30-min bars, G/L % in final 30-… https://t.co/obNlNBvr22
- $CSX $PPG: What Happened in the Stock Market Today: https://t.co/NnPonYSALj
- A Peek Into The Markets: US Stock Futures Down, Morgan Stanley... https://t.co/dE2WWiO3RC $BBT $CBSH $CSX #premarket @benzingaさんから
- CSX $CSX Shares Gap Down Following Analyst Downgrade https://t.co/txuG88l2zj
- $UNP $CSX: Four Items to Watch When Union Pacific Reports Earnings: https://t.co/J0Q7oNaKvU
- CSX Co. $CSX Given Consensus Recommendation of “Buy” by Analysts https://t.co/Bs4mBf2Pba
- $JBHT $CSX $KSU $NSC $UNP: Shares of JB Hunt Jump on Earnings Report: https://t.co/n5U4FZ9um4
- Today's Video: https://t.co/EHwLsjHnoE Stocks In The News, Now Trade It: $MS , $AA , $TSM , $CSX & More
- RT @BrandonVanZee: 9 at 9™ – 01/17/19 https://t.co/EW27WLfoYg via @market_scholars #9at9 #premarket #stocks + $PCG $MTB $BDX $CBS $SQ $APY…
- Analysts' Perspective on $CSX, $JWN, $SIMO, $TA, $SAVE, $UAL https://t.co/jzTQBlZBK1
- $CSX I.V. in the ATM 18-Jan-19 Decreases -61.2%. Options Imply a Move of ±1.4% with 1 Days to Exp https://t.co/vOqu9YHaCb
- $CSX This missed slightly on #Earnings But what most of you don't understand about this stock is it always gets bou… https://t.co/utUH8GcNi3
- top money flow Thursday ( price x volume ) $AMZN $NFLX $AAPL $BAC $MSFT $BABA $FB $MS $NVDA $AMD $GS $SQ $FISV $JPM… https://t.co/gC1s2TC2sY
- CSX $CSX Shares Gap Down on Analyst Downgrade https://t.co/3SWn0pneV7
- CSX $CSX Shares Gap Down Following Analyst Downgrade https://t.co/iDU7wf2U2c
- The Only Watchlist youll need this month : $low $adp $ba $wba $jnj $nflx $csx $gld $mcd $sbux $cvx $adsk $intc… https://t.co/54QmBHYqWt
- $CSX has said they will be doing a $5B #stock #buyback In #earnings report they earned $1.01 per share v… https://t.co/s8ZKm63bpV
- RT @AjTrader7: TODAYS LIVE TRADING WEBINAR RE-CAP FOR 1/17/2019 $LPCN SHORT $3.5 to $2 $NFLX LONG $347 to $355 $SIG SHORT $28 to $25 $LMFA…
- RT @AjTrader7: $CSX This missed slightly on #Earnings But what most of you don't understand about this stock is it always gets bought up on…
- RT @____Steeze: The Only Watchlist youll need this month : $low $adp $ba $wba $jnj $nflx $csx $gld $mcd $sbux $cvx $adsk $intc $pep $v $at…
- Trust Company Of Virginia Has Decreased Position in Csx $CSX by $1.19 Million; Charter Communications $CHTR Stake H… https://t.co/4PYB7C9teT
- Explore #fundamental numbers and pros and cons for $CSX https://t.co/YTsq7YalKO
- RT @LiveSquawk: Chevron: UBS Upgrades To Buy From Neutral – RTRS $CSX
- RT @LiveSquawk: Chevron: UBS Upgrades To Buy From Neutral – RTRS $CSX
- Chevron: UBS Upgrades To Buy From Neutral – RTRS $CSX
- Wellington Shields Capital Management Stake In Csx $CSX Was Increased; Seizert Capital Partners Has Lifted Its Walm… https://t.co/jT8Wsdok8V
- $UNP Four Items to Watch When Union Pacific Reports Earnings @themotleyfool #stocks $UNP, $CSX https://t.co/FISeoDIFdO
- Btw, Estimated #Earnings Per Share for $CSX is $0.62 it's 0.95% of the current price https://t.co/rJW10p6J3B
- Zacks Investment Research Upgrades CSX $CSX to Buy https://t.co/QpewbQ3Z86
- Csx Corp $CSX Holder Ci Global Investments INC Has Cut Position https://t.co/96PrHZT3F7
- J.B. Hunt Shares Rose 6% after Strong Q4 Results $JBHT $CSX $CHRW $WERN $IYT https://t.co/1bsDLs4Lfn https://t.co/57fHdymcNp
$KEY
- Brokerages Set KeyCorp $KEY Target Price at $22.21 https://t.co/MYglFFEOvb
- KeyCorp $KEY Receives $22.21 Average Target Price from Brokerages https://t.co/ntH0FJCQpk
- 5 Altcoins That Could Move Into the Top 100 in 2019 $HYDRO $IQ $REQ $KEY $AGI Full Story: https://t.co/I99pffZcYY https://t.co/6flGdvDpf8
- you'll need $KEY to lock up the door. Just bought a bag of them. #selfkey #IHAVEABACKPACK
- Scan results - Fell Below 50 DMA today: $QTNA $HOMB $KEY $ERJ $EBS $LASR $WLH $LOW $IPHI $ETR $NAVI $JNPR $UNH $ALK… https://t.co/1czM1lBnZa
- $key çok ağırsın ya. Haydi bastır yetmez bu kadar https://t.co/HNvrLuJoP5
- KuCoinのコイン価格と変動率をリスト表示するページを作りました! 毎日のチェックにどうぞ。 #KuCoin $BTC $BCH $KCS $RPX $XRB $NEO $ETH $BTG $LTC $KEY $CAN… https://t.co/sPFXklKMMM
- $PCG will be removed from the $SPX Friday but they lost over 9% today making them Thursday's worst performing $SPX… https://t.co/7Eo9DnPpGn
- RT @iiblockchain: 5 Altcoins That Could Move Into the Top 100 in 2019 $HYDRO $IQ $REQ $KEY $AGI Full Story: https://t.co/I99pffZcYY https:…
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/ZyCMIEy0D7
- RT @EnaCrypto: #key $key #keybtc HEG 0-0 geldi Görünüm aşağıda. https://t.co/HmloO6fFOf
- $KEY #selfkey Time to break major resistance at 1) 115 sats. 2) 140 sats 3) mars #crypto #altszn https://t.co/CBxPi0NJXA
- #key $key #keybtc HEG 0-0 geldi Görünüm aşağıda. https://t.co/HmloO6fFOf
- Scan results - MACD Bullish Centerline Cross today: $HA $FOSL $KNX $PPG $MTB $KEY $DRH $WST $EQR $JW.A $WPX $PPBI… https://t.co/PemalImhEF
- RT @EnaCrypto: #key $key #keybtc HEG 0-0 geldi Görünüm aşağıda. https://t.co/HmloO6fFOf
- And there goes 80 sats for $KEY! https://t.co/vp1igezsxb
- $KEY powering up its engines! Great volume and strong OBV. https://t.co/6W8qj9ofXE
- Got some really good entries this week for alts. Think we had about 7 calls this week and I believe all are up.… https://t.co/nFjuzx8q9W
- Told y’all $btc $trx $xrp $hot $xvg Watch $key #selfkey fly
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/05KalVLBca
- $key geliyor nazlı yarim :)) gerçi 2 gün olmuş vereli 72 sats dan. % 10. Uyuz bi koin $lrc gibi vermez ki %70 2 gün… https://t.co/Zkx2wcj9oL
- $KEY Qualitative Analysis of earnings call reveals continued growth in loans and deposits, all-time highs in severa… https://t.co/82n5waIeEo
- Scan results - MACD Bullish Centerline Cross today: $HSE $MPH $CSH.UN $PSD $ECA $WTE $NXR.UN $TCN $CP $ATA $ADN… https://t.co/A0DvXv0zqv
- Scan results - Crossed Above 50 DMA today: $HSE $WTER $MTL $GBR $NNO $BIP.UN $BAM.A $GWO $RVX $CP $IFC $ATA $ADN… https://t.co/bIMuNj7u4s
- RT @IncomeSharks: Got some really good entries this week for alts. Think we had about 7 calls this week and I believe all are up. $TNT, $GN…
- RT @IncomeSharks: Got some really good entries this week for alts. Think we had about 7 calls this week and I believe all are up. $TNT, $GN…
- RT @IncomeSharks: Got some really good entries this week for alts. Think we had about 7 calls this week and I believe all are up. $TNT, $GN…
- RT @theflynews: Fly Intel: Pre-market Movers $MS $LPCN $ZFGN $INSM $CARS $BBT $KEY $FAST $EA $RVNC $ACB $MTB https://t.co/Py1eO20uwh
- $NSPX 0027? CANCER PATENT GRANTED 130MIL O\S! $NVCN $SPY $GDX $FB $RNVA $BAC $GE $XLF $EEM $HLT $TVIX $QQQ $MU $KEY… https://t.co/9gAtBNeGwE
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/6Rxoy4iZL7
- @BitcoinOverdose Lets see which one goes up first. My guess would be $key. Fingers crossed.
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/RBea628rNr
- RT @BillGK_Trading: $KEY #Selfkey Attempting to break out of this tight 5 week consolidation channel. The last two times (in red) its mom…
- $KEY #Selfkey Attempting to break out of this tight 5 week consolidation channel. The last two times (in red) its… https://t.co/TxR0j43yX9
- SelfKey is one of a number of projects that is trying to provide self-sovereign identity management on the blockcha… https://t.co/UkQhaIl6ha
- RT @IncomeSharks: Got some really good entries this week for alts. Think we had about 7 calls this week and I believe all are up. $TNT, $GN…
- Make money by capitalizing on BTC volatility https://t.co/2NuQB72yfM #BITMEX #BTC #ADA #XRP #BCH #EOS #X10 #X20… https://t.co/fW2m5WfKim
- Make money even when BTC is going down! https://t.co/2NuQB72yfM #BITMEX #BTC #ADA #XRP #BCH #EOS #X10 #X20 $EOS… https://t.co/RWo434xQEY
- Make money even when BTC is going down! https://t.co/2NuQB72yfM #BITMEX #BTC #ADA #XRP #BCH #EOS #X10 #X20 $EOS… https://t.co/I8mNgTAqSs
- You can see Our Pro group Made Day Profit And Have a Good accuracy ! https://t.co/2NuQB72yfM #BITMEX #BTC #ADA… https://t.co/r6kHxENxnh
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/zaPTpQwXld
- most active stocks Thursday - $BAC $GE $PCG $AMD $FDC $F $MS $ACB $ECA $MU $AAPL $VALE $SNAP $KEY $MSFT $WFC $KMI… https://t.co/pSSfLqeCRm
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/wKW51YOCVM
- See October's results!!! For more signals,join telegram- https://t.co/oWOFCPOmVs $GAS #populous #news $TEL #ethos… https://t.co/fYL37Nh5Ld
- RT @IncomeSharks: Got some really good entries this week for alts. Think we had about 7 calls this week and I believe all are up. $TNT, $GN…
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/c2E0zZxgyJ
- $KEY Max Pain=15.50. Maturity=01/25/2019. #maxpain #options https://t.co/l3kyAtshxu https://t.co/BA2jKuJsC0
- Downgrades $BVN $KMX $IMMU $PPG $DK $IPG $LN $EEX $CASA $SIG $IAG $KEY $X $NLS $SASR $LKQ $LOXO $ED $KEY
- Hedeker Wealth Management Group Has Increased Keycorp Com $KEY Holding by $1.24 Million as Market Valuation Decline… https://t.co/pRfI7Sa2qH
- I bought $KEY again in this dip I still have half of the previous position
- What Can We Expect after a KeyCorp $KEY Downgrade from Outperform to Market Perform Rating? https://t.co/49eiV9YfSZ
- As Key $KEY Share Value Declined, Shareholder South State Has Lowered by $667,109 Its Position; Tri Contl Com $TY S… https://t.co/Utg4bduXUF
- FY2018 Earnings Forecast for KeyCorp Issued By Wedbush $KEY https://t.co/sdreX2zua9
- KeyCorp $KEY Lowered to “Market Perform” at BMO Capital Markets https://t.co/63d3s53rKe
- FY2018 Earnings Forecast for KeyCorp Issued By Wedbush $KEY https://t.co/c0j1vawxps #stocks
- Belden $BDC Holding Upped by Southernsun Asset Management Llc; Keycorp New $KEY Stake Held by Zeke Capital Advisors… https://t.co/CH44kE2mV7
- Binance has over 12 million users! Join the #1 Crypto Exchange https://t.co/GxqrML0YSN $MAID $POLY $DOCK $ITC… https://t.co/5IsmJC7XJn
- Wedbush Sets KeyCorp FY2018 Earnings Estimates at $1.74 EPS. https://t.co/NZNK6pfcYw $KEY #KEY
$PFE
- Top #moneyflow for #sp500 today $BMY $PCG $PFE $BAC $DNB $MS $NKE $CSCO $JNJ $JPM ... https://t.co/S59zN0R1wP
- $ARYC _ Arrayit Corporation CEO Letter to Shareholders https://t.co/THM8v3Tezz $CELZ $PFE, $SHLDQ, $FNMA, $SURG,… https://t.co/OE7rbcqoPq
- social trending scan $NFLX, $BA, $BABA, $FOSL, $AXP, $X, $CAT, $PFE, $CLF, $OKTA, $ATTU, $CENX, $AMD https://t.co/l3robeiTGc
- $ARYC _ https://t.co/RRTsAotxqB $CELZ $PFE, $SHLDQ, $FNMA, $SURG, $SFIO, $DKSC, $AMFE, $FUSZ, $CANB, $CGC $SHMP… https://t.co/OOkBEy1bic
- Pfizer $PFE Holder Edge Wealth Management Has Decreased Position as Stock Price Rose; Banco Latinoamericano De Come… https://t.co/UaxfEQr6uA
- Graco $GGG Share Value Declined While Stonebridge Capital Advisors Raised by $1.39 Million Its Position; As Pfizer… https://t.co/GGdX5vYYR3
- Marsh & Mclennan Cos $MMC Stock Price Declined While Apg Asset Management Nv Lifted Its Position; Pfizer $PFE Holde… https://t.co/FgHOYbRyRM
- #estate asset watch - top money flow today ( price x volume ) $AMZN $NFLX $AAPL $BAC $MSFT $BABA $FB $MS $NVDA $AMD… https://t.co/KI7OOBK1BB
- Will US ease trade tariffs on China during talks? $spy $dia $iwm $uso $gld $fxi $baba $sina $bidu $xle $xlf $xlk… https://t.co/L6cir7huCr
- #Options #maxpain chart for $PFE. Free options app https://t.co/wPNDm22czd https://t.co/ARCEDV7D02
- Popular: $CVS, $REGN, $PFE
- RT @duelittle2: $ARYC _ Arrayit Corporation CEO Letter to Shareholders https://t.co/THM8v3Tezz $CELZ $PFE, $SHLDQ, $FNMA, $SURG, $SFIO, $…
- RT @duelittle2: $ARYC _ https://t.co/RRTsAotxqB $CELZ $PFE, $SHLDQ, $FNMA, $SURG, $SFIO, $DKSC, $AMFE, $FUSZ, $CANB, $CGC $SHMP $RXMD, $V…
- RT @duelittle2: $CELZ _ https://t.co/Kv8yNrgdbH $PFE, $SHLDQ, $FNMA, $SURG, $SFIO, $DKSC, $AMFE, $FUSZ, $CANB, $CGC $SHMP $RXMD, $VPLM,…
- https://t.co/QpzIZ68ulC review I’ve been a member of Jason Bond Picks for 2 years and made some serious profits! $GPRO $FIT $PFE
- $CELZ _ https://t.co/Kv8yNrgdbH $PFE, $SHLDQ, $FNMA, $SURG, $SFIO, $DKSC, $AMFE, $FUSZ, $CANB, $CGC $SHMP $RXMD… https://t.co/6m6ZfSbg0F
- https://t.co/ebgF3HoHz1 < [Review] The best swing trading service on Wall Street!!! $PFE $BABA $SWN
- Short sale volume(not short interest) for $INCY on 2019-01-16 is 53%. https://t.co/kUKQfn2p4e $PFE 33% $AVEO 63% $LLY 50% $NVS 22%
- 2019-01-16 Short sale volume (not short interest) for $CLDX is 45%. https://t.co/l6L5TjJrmf $PFE 33% $GSK 58% $BMY 47% $SGEN 54%
- $ZTS short ratio is 2.16 at 2018-12-31 https://t.co/rWxJqbio95 $MRK 3.09 $LLY 1.70 $PFE 1.72
- $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future.… https://t.co/CbYLSPQw1x
- $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued oper… https://t.co/fFjE2yOT4c
- $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent fil… https://t.co/Z5IZhcc7OF
- $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal… https://t.co/G23vFDY2Yj
- $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-… https://t.co/vEevaMBmxd
- $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already… https://t.co/hBPWg90vih
- $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been ide… https://t.co/1IiCdBZK3z
- $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA… https://t.co/g9DOPOwSyq
- $NSPX signed commitment letter w\ Milost Global Inc agreeing 2 terms 4 a commitment of up to $100 MILLION $AAPL… https://t.co/NhA3XTwaPp
- $NSPX Sabby capital 1.8bil hedgefund specialize in BIG #BIOTECH why LOAD a pennystock?! https://t.co/p2lvo3BQAx… https://t.co/esvJBbeEZ6
- RT @StockTweetsHQ: UPDATED: A Done Deal_Amarin $AMRN Will Confirm New Partnership Agreement With Pfizer $PFE As Early As Next Week https://…
- Investors Sell Pfizer $PFE on Strength $PFE https://t.co/Kp14pZVM2I
- Investors Sell Pfizer $PFE on Strength $PFE https://t.co/gNqnIjyFKC
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and… https://t.co/m2hFXKK6eD
- $PAOG _ Cannophen https://t.co/fnNr4rXZEx https://t.co/3RfMZvXWt1 https://t.co/hph4iIwxsf $PFE, $SHLDQ, $FNMA,… https://t.co/b8hnoU9fKp
- short ratio of $LLY is 1.70 at 2018-12-31 https://t.co/FcAhBfPVDz $JNJ 1.04 $MRK 3.09 $PFE 1.72
- 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group https://t.co/KrfgpttziQ $PNC $PFE $FISV
- Short sale vol (not short interest) for $ABT on 2019-01-17 is 57%. https://t.co/lpCa2LthUS $BSX 42% $BMY 48% $JNJ 46% $PFE 36%
- RT @_B_I_O_T_E_C_H_: #Genetherapy, #celltherapy and #geneediting are fields of biomedical research with a similar goal in mind: To treat di…
- The Biggest Dividend Stocks From The Healthcare Sector - #Pfizer #UnitedHealth #Novartis #Amgen #Medtronic… https://t.co/QYuRNBIdQ3
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- top money flow Thursday ( price x volume ) $AMZN $NFLX $AAPL $BAC $MSFT $BABA $FB $MS $NVDA $AMD $GS $SQ $FISV $JPM… https://t.co/gC1s2TC2sY
- RT @_B_I_O_T_E_C_H_: #Genetherapy, #celltherapy and #geneediting are fields of biomedical research with a similar goal in mind: To treat di…
- most active stocks Thursday - $BAC $GE $PCG $AMD $FDC $F $MS $ACB $ECA $MU $AAPL $VALE $SNAP $KEY $MSFT $WFC $KMI… https://t.co/pSSfLqeCRm
- RT @DividendSheet: The Biggest Dividend Stocks From The Healthcare Sector - #Pfizer #UnitedHealth #Novartis #Amgen #Medtronic https://t.co/…
- Short Interest in Pfizer Inc. $PFE Declines By 16.6% https://t.co/lvKi43ZIIc
- #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-00… https://t.co/Xu0YJzHMiz
- #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for… https://t.co/Dd7XKlEfEZ
- #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QB… https://t.co/wZGx1gzeU2
- #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth i… https://t.co/sW6dPvdEPO
- #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimall… https://t.co/q1eKMTDggH
- RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has alre… https://t.co/BWIWBQPm8E
- RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally ver… https://t.co/FQcXFJUdB2
- RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent… https://t.co/eTUAtl2ElK
- RE: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued… https://t.co/AMq2nG8a7z
- RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut… https://t.co/vBEuDmAFCA
- Ironwood Investment Counsel Position in Sysco $SYY Has Trimmed by $378,286; Pfizer $PFE Stock Value Rose While Teac… https://t.co/CJRMV21rsx
- Pfizer $PFE to pay $0.36 on Mar 1, 2019; Whitman Education Group $WIX Sentiment Is 1.17 https://t.co/t9Vwh73wq1
- Pfizer $PFE Stock Rose While Jacobs & Co Cut by $369,028 Its Position; Centre Asset Management Holding in Viacom… https://t.co/9I7EdMKfp5
- RT @_B_I_O_T_E_C_H_: #Genetherapy, #celltherapy and #geneediting are fields of biomedical research with a similar goal in mind: To treat di…
- Drugmakers Raise Prices Amid Shortages, Recalls - WSJ where is #MartinShkreli to blame? #BigPharma $pfe $bmy $spy https://t.co/gqeKUeN0Rz
- Does #allergan Wish We Forgot About Setipiprant? $AAPL $AMZN $AGN $BRK $BHC $CRM $CMG $MYL $MRK $ENDP $TEVA $MS… https://t.co/qNc4OfhcUl
- Investors who choose to jump in now using the “Dogs of the Dow” strategy will be shooting for their fifth straight… https://t.co/L5xbHsd5Ph
- As Bb&T $BBT Stock Price Declined, Chesley Taft & Associates Raised Its Position; As Pfizer $PFE Valuation Rose, Sh… https://t.co/Ly4Gk154Fv
- As Pfizer INC Com $PFE Stock Value Rose, Piedmont Investment Advisors LLC Lowered Its Holding by $10.50 Million https://t.co/tVK4nVmLm7
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @EquitiesOB: RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @EquitiesOB: RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- RT @247BiotechNews: $QBIO $RHHBY Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 https://t.co/5RRkdoD0FO #FDA #Biotech #…
- RT @247BiotechNews: $QBIO $RHHBY According to the Centers for Disease Control and Prevention (CDC), about 1 in 68 children has been identif…
- RT @247BiotechNews: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @247BiotechNews: $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-001…
- RT @247BiotechNews: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @247BiotechNews: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @247BiotechNews: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @247BiotechNews: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @247BiotechNews: Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and $RH…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the future. Inv…
- RT @EquitiesOB: RE: $QBIO Q BioMed management believes that the company is well positioned to achieve revenue as well as continued operatio…
- RT @EquitiesOB: RE: $QBIO We look forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing…
- RT @EquitiesOB: RE: $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal and…
- RT @EquitiesOB: RE: $QBIO Q BioMed Inc., a New York based biomedical public company trading under the symbol (OTCQB: QBIO) has already one…
- RT @daily_otc: #BIOTECH $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimally verbal…
- RT @daily_otc: #BIOTECH RE: $QBIO Q BioMed Inc offers investors a winning drug development platform and the potential for growth in the fut…
- RT @daily_otc: #BIOTECH Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 and…
- RT @daily_otc: #BIOTECH $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee for its QBM-…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committee f…
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of min… https://t.co/5Oolrki11g
- #BIOTECH #FDA $QBIO announced Wednesday that Dr. Pamela Ventola of Yale University has joined its advisory committ… https://t.co/EcHJN4ZnY9
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- $PFE Pfizer https://t.co/1CtyeHp8hh Support 42.44 42.15 41.34 40.78 40.42 38.07 Resistance… https://t.co/Ogx8mDtGHl
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- RT @NasdaqReporter: #FDA Autism Spectrum Disorder: Top 2 Biotech Companies to Watch in 2019 $QBIO Q BioMed Inc., (OTCQB: QBIO) – QBM-001 an…
- CNBC DEBUNKED on #ALLERGAN? Your Call! Never BUY FRAUD! Intergrity! $AAPL $AMZN $AGN $BRK $BHC $CRM $CMG $MYL $MRK… https://t.co/pof90O1oZt
- Is Setipiprant Another Ex. Of #allergan FAILING TO Disclose BAD NEWS? News? $AAPL $AMZN $AGN $BRK $BHC $CRM $CMG… https://t.co/QWPJm24rPN
- Short sale vol (not short interest) for $SPXL on 2019-01-17 is 36%. https://t.co/jcIWmoKk9P $PFE 36% $NKE 46% $XLB 57% $RGSE 41%
- Barry Investment Advisors Lowered By $3.08 Million Its Pfizer $PFE Holding; Capital Fund Management Sa Upped Total… https://t.co/o82qqRwMGE
- #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of min… https://t.co/kKCmmi3pfx
- #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of min… https://t.co/s8t5bob5Tq
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- As Wintrust Finl $WTFC Stock Price Declined, Shareholder First Midwest Bank Trust Division Has Decreased Its Stake;… https://t.co/utUjL5Kk8P
- Pfizer $PFE Shareholder Wms Partners Raised Its Holding by $1.38 Million; Gabelli Securities Raised Position in Avi… https://t.co/YQPo6jb1oS
- Pfizer $PFE Shareholder Evercore Wealth Management Has Lowered Its Stake; Texas Capital Bancshares $TCBI Sharehold… https://t.co/Xw40XbfrW4
- $PFE Max Pain=42.50. Maturity=01/25/2019. #maxpain #options https://t.co/P8rDM3uiYG https://t.co/TdNXnkIirR
- Pfizer Inc. (PFE) Moves Higher on Volume Spike for February 09 https://t.co/FySeg4ArWj $PFE #stocks #stockmarket
- RT @NasdaqReporter: #BIOTECH #FDA $QBIO $RHHBY Q BioMed’s drug treatment QBM-001 is being developed and tested for the treatment of minimal…
- FRSBIGFUND trading system: https://t.co/FfkOdmQhFb trading investing $CRK $WMT $PFE $MAT $CSCO $BREW $MRK $NKE… https://t.co/Ywa1ZVSMH6
$DAL
- $DAL Delta Air Lines Inc. Option Order Flow Sentiment is 51.3% Bullish. https://t.co/tJFDcvvZqZ
- $ET $PCG $BAC $MRK $GGB $NKE $NOW $MO $UPS $I $GM $BBY $GE $USG $JNJ $BABA $DRI $DAL $XPO $ALB $H Largest MOC SELLS https://t.co/jkdXYla1h8
- The Best & Worst U.S. Airlines of 2018 ✈️ #investing #investment #investor #invest #wallstreet #stocks… https://t.co/RZVOz8A8fq
- $NFLX $C $BAC $JPM $UNH $DAL $WFC $GS $BLK $MS $AXP $AA $SJR $SLB $FAST $SPY $QQQ $PG $SCHW $FOXA $USB $BX $MOMO… https://t.co/6ujk2hd1pc
- RT @eWhispers: #earnings season $AAPL $NFLX $FB $BAC $C $JPM $GE $UNH $BA $DAL $CLF $T $GS $WFC $PYPL $GOOGL $INTC $F $TWTR $MA $V $JNJ $…
- Protected: Swing Trading Earnings | Video: Trade Set-Ups | $MS, $AXP, $C, $SJR, $BAC, $DAL, $NFLX, $SPY, $VIX… https://t.co/X74lvbCfXR
- Protected: Swing Trading Earnings | Video: Trade Set-Ups | $MS, $AXP, $C, $SJR, $BAC, $DAL, $NFLX, $SPY, $VIX… https://t.co/kkNFfh9n1Z
- $DAL DEATH CROSS 50 SMA < 200 SMA https://t.co/7rwRZdBWbl
- RT @TravisHoward5: #unusualoptionactivity $SPY $BAC $QQQ $GE $EEM $AAPL $AMD $FXI $IWM $XLF $SQ $FB $BABA $NVDA $JD $PBR $X $QCOM $TRIP $TS…
- #unusualoptionactivity $SPY $BAC $QQQ $GE $EEM $AAPL $AMD $FXI $IWM $XLF $SQ $FB $BABA $NVDA $JD $PBR $X $QCOM… https://t.co/550KMXPmsd
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- Delta Air Lines $DAL Given a $67.00 Price Target by Credit Suisse Group Analysts https://t.co/YPpH2OrhLx
- Delta Air Lines $DAL Given a $67.00 Price Target by Credit Suisse Group Analysts https://t.co/ZMkxcRxKK8
- Credit Suisse Group Reiterates “$67.00” Price Target for Delta Air Lines $DAL https://t.co/wa0BQokzYA
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- Delta Air Lines $DAL Stock Rating Lowered by Bank of America https://t.co/52RKxKLdFI
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- RT @ArabicWallSt: موسم الأرباح سيبدأ و لو أخذنا أكبر شركة في كل قطاع لو جدنا التالي: . 1- بالتقنية ابل $AAPL خفضت من توقعاتها ارباحها المست…
- Betting markets saying odds of Trump impeachment in in his 1st term are now 56% - highest level since his election.… https://t.co/I7cjOlSkFV
- As Delta Air Lines De Com New $DAL Shares Declined, Benchmark Capital Advisors Has Upped Its Position; West Coast F… https://t.co/GURZuFiPJp
- Delta Air Lines $DAL Upgraded by Zacks Investment Research to Buy https://t.co/867H14sTsg
- Delta Air Lines $DAL Upgraded by Zacks Investment Research to Buy https://t.co/m59jW9IiFL
- Alleghany Has Decreased Its Delta Air Lines Del $DAL Stake by $4.73 Million; 1Procter And Gamble Co $PG Holder Unio… https://t.co/Mma9KK10gl
- Retirement Systems Of Alabama Stake in Abbott Labs $ABT Has Cut by $1.03 Million; Gradient Investments Stake in Del… https://t.co/2rmyQPCgkg
- Investment House Cut By $330,315 Its Delta Air Lines Del $DAL Position; Galectin Therapeutics $GALT Sentiment Is 1.… https://t.co/mlV1fDjB9q
- Hartline Investment Increases Stake in Zillow Group Class A $Z; As Delta Air Lines $DAL Share Price Declined, Gene… https://t.co/MvA7P9FmQA
- $FB $BABA $AAPL $FCX $FFIV $FIT $GE $GERN $GILD $GM $GE $CELG $CGC $GS $HAL $HD $HDS $HON $HPQ $IBM $CTRP $CTSH… https://t.co/BwtLl8sd41
- Currently in security line at LaGuardia. Is it longer than normal for 7am? Yes. Is it oppressive? No. $dal $ual $save
- RT @StockTweetsHQ: Added Value_Guard Dog $GRDO Share Price To Begin Climbing As CEO George Sharp Confirms No Dilution And Equity Financing…
- Motley Fool Wealth Management Has Lowered Its Eastman Chemical Co $EMN Holding by $9.05 Million as Stock Value Decl… https://t.co/L7NoR649u9
$CNP
- Scan results - New 52 Week Closing High today: $CCC $ATTU $HYAC $THS $LOCO $CCC.U $OKTA $REGN $CRCM $CHGG $POST… https://t.co/EH78ILInDw
- Short sale volume(not short interest) for $D on 2019-01-16 is 41%. https://t.co/lSB9hLO5Re $DUK 50% $EXC 48% $CNP 55%
- $CNP open interest for maturity 02/15/2019. High put=27.00 High call=30.00 #maxpain #options https://t.co/s3Rrpb2WZP https://t.co/Mz3eImUmKH
- Johnson Investment Counsel Holds Holding in Starbucks Corp. $SBUX; Crow Point Partners Lowered Its Centerpoint Ener… https://t.co/LmbDTiUhNy
- Upgrades $SPB $KMB $CNP $EW $SPWH $VLO $CVX $CNP $CBSH $ACH $MDRX $ANET $FISV $IQV $E $TKC $LXFT
- RT @ACInvestorBlog: Upgrades $SPB $KMB $CNP $EW $SPWH $VLO $CVX $CNP $CBSH $ACH $MDRX $ANET $FISV $IQV $E $TKC $LXFT
- CenterPoint Energy $CNP Upgraded by Royal Bank of Canada to “Outperform” https://t.co/JDjPuNJago
- CenterPoint Energy $CNP Upgraded by Royal Bank of Canada to “Outperform” https://t.co/8SwnayntIp
- RBC Capital Raises their Rating for Shares of CenterPoint Energy $CNP. Are Other Analysts Next? https://t.co/84lbfSjyfC
- Just How Positive is RBC Capital on CenterPoint Energy $CNP Following Its Upgrade? The Target Price is $34 https://t.co/2tx2KXAWL4
$MET
- Sign up now to https://t.co/nlKr7xlSJq and jump on this BITMEX killer boat before too late ! $BTC $ETH $LTC… https://t.co/9X8my3ES4V
- Bulls double their money in $MET https://t.co/SyVsqTCfMd
- #rally #trade talks $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS… https://t.co/YL4wzQXAc9
- RT jonnajarian "Bulls double their money in $MET Read more: https://t.co/IdFpIzkpwy"
- Bulls double their money in $MET https://t.co/gwQ0MRMlu9 via investitute
- Bulls double their money in $MET Read more: https://t.co/SHtZ34fy32
- Sign up now to https://t.co/nlKr7xDu80 and jump on this BITMEX killer boat before too late !!! most trustworthy… https://t.co/nxplji3vq1
- $MET open interest for maturity 01/18/2019. High put=45.00 High call=50.00 #maxpain #options https://t.co/OpSfR3EPv7 https://t.co/JFT4DJ6SPu
- Sign up now to https://t.co/nlKr7xDu80 and jump on this BITMEX killer boat before too late !!! BTC / BCH deposi… https://t.co/dkQWes71SQ
- Sign up now to https://t.co/nlKr7xDu80 and jump on this BITMEX killer boat before too late ! $BTC $ETH $LTC… https://t.co/YA1r9U0kyK
- $HI! $BAM! $IT $MET $BIG
- Today's #metronome Daily Supply Lot: 2880 $MET Open 0.011855 ETH ($1.47), Final 0.005359 ETH ($0.66), 1 hours and 1… https://t.co/t3LITvCQBx
- $MET Metlife Inc. Option Order Flow Sentiment is 58.4% Bullish. https://t.co/0F5Y81bwLK
- Sign up now to https://t.co/nlKr7xlSJq and jump on this BITMEX killer boat before too late !!! BTC / BCH deposi… https://t.co/P3y5LzQPny
- RT @raymond10mm: #rally #trade talks $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS $UNH $V…
- EPS for MetLife, Inc. $MET Expected At $1.31 https://t.co/Uh1UBrr8hW
- MetLife, Inc. $MET EPS Estimated At $1.31 https://t.co/2Zylx1jEya
- MetLife, Inc. $MET Analysts See $1.31 EPS https://t.co/xoy5kvyNP5
- EPS for MetLife, Inc. $MET Expected At $1.31 https://t.co/Bdf9fexE9k
- Sign up now to https://t.co/nlKr7xlSJq and jump on this BITMEX killer boat before too late !!! most trustworthy… https://t.co/lSjXD0FCgf
- $SWAY $TOO $BIG $HE $MET $MR $FIT $TOO $RAD $CUBS $ARE $TWO $HUBS
- Quality undervalued stocks like $PHM, $HFC and $MET showing up in our Fundamental Piotroski F-score screen. https://t.co/f2XguSPSA6
- Sign up now to https://t.co/nlKr7xDu80 and jump on this BITMEX killer boat before too late !!! most trustworthy… https://t.co/hfgaGzkeO9
- Sign up now to https://t.co/nlKr7xDu80 and jump on this BITMEX killer boat before too late ! $BTC $ETH $LTC… https://t.co/Ce8DVEqZjK
- Sign up now to https://t.co/nlKr7xlSJq and jump on this BITMEX killer boat before too late ! $BTC $ETH $LTC… https://t.co/9cqnQJGjEA
- Sign up now to https://t.co/nlKr7xDu80 and jump on this BITMEX killer boat before too late !!! BTC / BCH deposi… https://t.co/s4mQ38OX7h
- $LNC short % to float is 1.55% https://t.co/dP3pVQUly1 $PRU 1.14% $VOYA 6.92% $MET 1.36% $CNO 1.55%
$GLNG
- RT @OpenOutcrier: RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $Z…
- RT @OpenOutcrier: RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $Z…
- RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $ZNGA
- RT @OpenOutcrier: RECAP 1/17 Unusual Calls: $TWTR $ITB $EBAY $ARNC $ACB $MSFT $CS $VST $CVE $VIPS $CPE $SQ $GLNG $NIO $WP $MRK $PCG $BMY $Z…
- Unusual calls: $ACB $ZNGA $MRK $BMY $MSFT $CS $CVE $EBAY $NIO $PCG $ARNC $VIPS $SQ $GLNG
- RT @TopStockAlerts1: Unusual calls: $ACB $ZNGA $MRK $BMY $MSFT $CS $CVE $EBAY $NIO $PCG $ARNC $VIPS $SQ $GLNG
- Golar Lng LTD Bermuda $GLNG Shareholder Granite Point Capital Management LP Has Decreased Its Stake; Martin Mariett… https://t.co/XRI5Q7Fbif
$MNST
- RT @NasdaqDearborn: Happy to welcome $MNST for the closing Bell! @Nasdaq https://t.co/lFFR3yln8x
- Programmers keep $MNST in the @Nasdaq
- Including Reign, the $MNST response to Bang https://t.co/NY2HEtQluq
- RT @NasdaqDearborn: Happy to welcome $MNST for the closing Bell! @Nasdaq https://t.co/lFFR3yln8x
- $MNST growing value share in virtually every single market around the world https://t.co/0gQi3ms3o3
- Happy to welcome $MNST for the closing Bell! @Nasdaq https://t.co/lFFR3yln8x
- RT @NasdaqDearborn: Happy to welcome $MNST for the closing Bell! @Nasdaq https://t.co/lFFR3yln8x
- RT @BeverageDigest: Here's @MonsterEnergy's update on arbitration with @CocaColaCo over a Coke-branded energy drink overseas...from today's…
- Popular: $IMMU, $GPOR, $MNST, $NLS, $PBCT
- Here's @MonsterEnergy's update on arbitration with @CocaColaCo over a Coke-branded energy drink overseas...from tod… https://t.co/VOGjEZbsAm
- Remember when $MNST used to be HANS? Reviewing @IBDinvestors Lesson 11 Post Analysis @IBDMeetup. This lesson demon… https://t.co/TwA97f5CJY
- Monster Beverage’s $MNST Buy Rating Reaffirmed at Jefferies Financial Group https://t.co/9ccCAyYoY2
- RT @NasdaqDearborn: Happy to welcome $MNST for the closing Bell! @Nasdaq https://t.co/lFFR3yln8x
- Do you know that #Book Value for $MNST is $7.04 https://t.co/KQuFiMcRQs
$PNR
- $PNR $PNR.AX very solid performance, easily taking out supply. Would like to see some consol here before next move.… https://t.co/smeJGSJPr8
- Rose Above Upper Bollinger Band today: $PNR ... https://t.co/wNoQlsgkjQ
- Pantoro Limited $PNR Rise 2.04% on Jan 18 https://t.co/AAqiTTEAXr
- How Analysts Rated Pentair plc $PNR Last Week? https://t.co/G9M0JVMzBq
- Can analysts adopt a bullish outlook for Pentair plc $PNR? https://t.co/StXNl4OKib
- Pentair plc $PNR has analysts on the Bullish side this week. https://t.co/RLrmPZbCm5
- Were Analysts Bullish Pentair plc $PNR This Week? https://t.co/AjDhYJZSsT
- Pentair Plc $PNR Shareholder Mairs & Power Trimmed Its Position by $6.52 Million as Stock Price Declined; Boussard… https://t.co/WgEX2qJXbW
- BidaskClub top 50 #OntheirOwn $LII $VOD $RHT $AGIO $FFBC $HSTM $MAC $IRWD $AVA $ZLAB $ABBV $VEON $RHP $PSMT $ZTO… https://t.co/XhiYwVcFEP
1)
quote {symbol JEC companyName {Jacobs Engineering Group Inc.} primaryExchange {New York Stock Exchange} sector Industrials calculationPrice previousclose open 59.63 openTime 1547735400203 close 60.52 closeTime 1547758921475 high 61 low 59.318 latestPrice 60.52 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 7 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 60.52 delayedPriceTime 1547758921475 extendedPrice 60.52 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547816737020 previousClose 60.52 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1381673 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 8614135200 peRatio 13.66 week52High 82.2395 week52Low 55.17 ytdChange 0.03488372093023267}
2)
quote {symbol BMY companyName {Bristol-Myers Squibb Company} primaryExchange {New York Stock Exchange} sector Healthcare calculationPrice previousclose open 49.16 openTime 1547735400159 close 49.6 closeTime 1547758826088 high 49.885 low 48.471 latestPrice 49.6 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 10889 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 49.6 delayedPriceTime 1547758826088 extendedPrice 49.93 extendedChange 0.33 extendedChangePercent 0.00665 extendedPriceTime 1547820188125 previousClose 49.6 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 16101747 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 80970245003 peRatio 13.33 week52High 70.05 week52Low 44.3 ytdChange -0.04652056901191852}
3)
quote {symbol BSX companyName {Boston Scientific Corporation} primaryExchange {New York Stock Exchange} sector Healthcare calculationPrice previousclose open 36.55 openTime 1547735409294 close 36.81 closeTime 1547758868009 high 37.245 low 36.42 latestPrice 36.81 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 711 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 36.81 delayedPriceTime 1547758868009 extendedPrice 37 extendedChange 0.19 extendedChangePercent 0.00516 extendedPriceTime 1547820097482 previousClose 36.81 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 7532762 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 50937706749 peRatio 25.74 week52High 39.44 week52Low 25.04 ytdChange 0.06819500870574584}
4)
quote {symbol HT companyName {Hersha Hospitality Trust Class A of Beneficial Interest} primaryExchange {New York Stock Exchange} sector {Real Estate} calculationPrice close open 17.19 openTime 1547735400404 close 17.65 closeTime 1547758921999 high 17.67 low 17.14 latestPrice 17.65 latestSource Close latestTime {January 17, 2019} latestUpdate 1547758921999 latestVolume 420812 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 17.65 delayedPriceTime 1547758921999 extendedPrice 17.65 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547759622920 previousClose 17.26 change 0.39 changePercent 0.0226 iexMarketPercent 0 iexVolume 0 avgTotalVolume 512536 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 695829417 peRatio 8.44 week52High 24.16 week52Low 16.5 ytdChange 0.076331343283582}
5)
quote {symbol BHF companyName {Brighthouse Financial Inc.} primaryExchange {Nasdaq Global Select} sector {Financial Services} calculationPrice previousclose open 34.94 openTime 1547735400793 close 35.52 closeTime 1547758800698 high 35.6 low 34.71 latestPrice 35.52 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 7 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 35.52 delayedPriceTime 1547758800698 extendedPrice 35.52 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547816737486 previousClose 35.52 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1791612 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 4212715761 peRatio 5.7 week52High 67.55 week52Low 28.52 ytdChange 0.11979823455233306}
6)
quote {symbol PBCT companyName {People's United Financial Inc.} primaryExchange {Nasdaq Global Select} sector {Financial Services} calculationPrice previousclose open 15.65 openTime 1547735400931 close 16 closeTime 1547758800268 high 16.03 low 15.65 latestPrice 16 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 54 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 16 delayedPriceTime 1547758800268 extendedPrice 16.74 extendedChange 0.74 extendedChangePercent 0.04625 extendedPriceTime 1547820010973 previousClose 16 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 4404308 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 6040224416 peRatio 12.7 week52High 20.26 week52Low 13.66 ytdChange 0.08917631041524851}
7)
quote {symbol DWDP companyName {DowDuPont Inc.} primaryExchange {New York Stock Exchange} sector {Basic Materials} calculationPrice previousclose open 55.43 openTime 1547735499590 close 57.04 closeTime 1547758863617 high 57.09 low 55.33 latestPrice 57.04 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 2021 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 57.04 delayedPriceTime 1547758863617 extendedPrice 57.04 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547820133588 previousClose 57.04 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 12742209 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 130863667265 peRatio 14.05 week52High 77.08 week52Low 48.89 ytdChange 0.04622157006603074}
8)
quote {symbol CSX companyName {CSX Corporation} primaryExchange {Nasdaq Global Select} sector Industrials calculationPrice previousclose open 63.96 openTime 1547735400360 close 65.09 closeTime 1547758800696 high 65.26 low 63.14 latestPrice 65.09 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 1804 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 65.09 delayedPriceTime 1547758800696 extendedPrice 65.09 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547820134013 previousClose 65.09 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 6146637 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 54963321297 peRatio 16.91 week52High 76.24 week52Low 48.43 ytdChange 0.0506860371267151}
9)
quote {symbol KEY companyName KeyCorp primaryExchange {New York Stock Exchange} sector {Financial Services} calculationPrice previousclose open 16.5 openTime 1547735450708 close 16.33 closeTime 1547758900070 high 16.59 low 15.91 latestPrice 16.33 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 10508 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 16.33 delayedPriceTime 1547758900070 extendedPrice 16.4 extendedChange 0.07 extendedChangePercent 0.00429 extendedPriceTime 1547820060072 previousClose 16.33 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 12833813 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 16893881791 peRatio 10.02 week52High 22.4 week52Low 13.655 ytdChange 0.08721704394141137}
10)
quote {symbol PFE companyName {Pfizer Inc.} primaryExchange {New York Stock Exchange} sector Healthcare calculationPrice previousclose open 41.89 openTime 1547735423375 close 42.47 closeTime 1547758897733 high 42.66 low 41.83 latestPrice 42.47 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 2180590 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 42.47 delayedPriceTime 1547758897733 extendedPrice 42.47 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547820133129 previousClose 42.47 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 26798893 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 245496755328 peRatio 14.25 week52High 46.47 week52Low 33.2 ytdChange -0.01803468208092488}
11)
quote {symbol DAL companyName {Delta Air Lines Inc.} primaryExchange {New York Stock Exchange} sector Industrials calculationPrice previousclose open 47.44 openTime 1547735400047 close 48.22 closeTime 1547758842690 high 48.57 low 47.32 latestPrice 48.22 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 2157 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 48.22 delayedPriceTime 1547758842690 extendedPrice 48.42 extendedChange 0.2 extendedChangePercent 0.00415 extendedPriceTime 1547820226845 previousClose 48.22 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 8598807 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 33060533762 peRatio 8.6 week52High 61.32 week52Low 45.08 ytdChange -0.037332800958275195}
12)
quote {symbol CNP companyName {CenterPoint Energy Inc (Holding Co)} primaryExchange {New York Stock Exchange} sector Utilities calculationPrice previousclose open 29.48 openTime 1547735400203 close 29.54 closeTime 1547758950546 high 29.67 low 29.4 latestPrice 29.54 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 31 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 29.54 delayedPriceTime 1547758950546 extendedPrice 29.54 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547816737156 previousClose 29.54 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 5674903 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 14805193572 peRatio 18.82 week52High 29.72 week52Low 24.81 ytdChange 0.05499999999999997}
13)
quote {symbol MET companyName {MetLife Inc.} primaryExchange {New York Stock Exchange} sector {Financial Services} calculationPrice previousclose open 44.64 openTime 1547735409543 close 45.05 closeTime 1547758971274 high 45.29 low 44.26 latestPrice 45.05 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 63 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 45.05 delayedPriceTime 1547758971274 extendedPrice 45.05 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547820133088 previousClose 45.05 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 7433424 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 44457063253 peRatio 8.75 week52High 55.21 week52Low 37.76 ytdChange 0.08111351091912636}
14)
quote {symbol GLNG companyName {Golar LNG Limited} primaryExchange {Nasdaq Global Select} sector Industrials calculationPrice close open 22.3 openTime 1547735400663 close 22.52 closeTime 1547758800394 high 22.69 low 21.82 latestPrice 22.52 latestSource Close latestTime {January 17, 2019} latestUpdate 1547758800394 latestVolume 1292188 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 22.52 delayedPriceTime 1547758800394 extendedPrice 22.52 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547760869272 previousClose 22.51 change 0.01 changePercent 0.00044 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1390579 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 2281276000 peRatio -27.8 week52High 35.54 week52Low 20.49 ytdChange -0.004860353356890503}
15)
quote {symbol MNST companyName {Monster Beverage Corporation} primaryExchange {Nasdaq Global Select} sector {Consumer Defensive} calculationPrice previousclose open 53.9 openTime 1547735400397 close 54.27 closeTime 1547758800415 high 54.67 low 53.89 latestPrice 54.27 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 342 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 54.27 delayedPriceTime 1547758800415 extendedPrice 54 extendedChange -0.27 extendedChangePercent -0.00498 extendedPriceTime 1547820241441 previousClose 54.27 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 3884514 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 30009328114 peRatio 31.55 week52High 70.215 week52Low 47.61 ytdChange 0.11300246103363423}
16)
quote {symbol PNR companyName {Pentair plc.} primaryExchange {New York Stock Exchange} sector Industrials calculationPrice previousclose open 39.95 openTime 1547735400556 close 40.36 closeTime 1547759035773 high 40.765 low 39.87 latestPrice 40.36 latestSource {Previous close} latestTime {January 17, 2019} latestUpdate 1547683200000 latestVolume 11 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 40.36 delayedPriceTime 1547759035773 extendedPrice 40.36 extendedChange 0 extendedChangePercent 0 extendedPriceTime 1547818503505 previousClose 40.36 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1753885 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 7006537571 peRatio 13.19 week52High 74.66 week52Low 35.3 ytdChange 0.0685729414879533}